John T. Treace, Chief Executive Officer at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 163,340 shares at $17.44 ($2.7M) on 2021-12-27, disclosed to the SEC on 2021-12-27.
Open-market sale of $2.7M TMCI by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.29 | 41,710 | $679K | 24.9% |
| 2 | $16.29 | 41,710 | $679K | 24.9% |
| 3 | $16.96 | 22,795 | $387K | 14.2% |
| 4 | $16.96 | 22,795 | $387K | 14.2% |
| 5 | $17.44 | 17,165 | $299K | 11.0% |
| 6 | $17.44 | 17,165 |
| $299K |
| 11.0% |
| Total | $16.72 avg | 163,340 | $2.7M | 100% |
| Filing → |
| TMCI | BUY | 2026-06-11 | $211K | — | Filing → |
| TMCI | BUY | 2026-06-01 | $178K | — | Filing → |
| TMCI | BUY | 2026-05-28 | $341K | — | Filing → |